Holen Sie sich die Stockscreener-App
35.56
3.07%
1.06
Handel nachbörslich:
35.98
0.42
+1.18%
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
Where Harmony Biosciences Hldgs Stands With Analysts - Benzinga
Oppenheimer Sets $61 Price Target for Harmony Biosciences (HRMY) | HRMY Stock News - GuruFocus
(HRMY) On The My Stocks Page - news.stocktradersdaily.com
Oppenheimer assumes Outperform rating on Harmony Biosciences stock By Investing.com - Investing.com India
Harmony Biosciences (HRMY) Receives Outperform Rating from Oppen - GuruFocus
Oppenheimer Assumes Harmony Biosciences Holdings Inc. (HRMY) at Outperform - StreetInsider
Nuveen Asset Management LLC Buys 8,193 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Top 5 US Stocks To Buy In June 2025 - Investing.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bank of America Corp DE Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Ameriprise Financial Inc. Purchases 18,730 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of “Buy” by Analysts - Defense World
When (HRMY) Moves Investors should Listen - news.stocktradersdaily.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Deutsche Bank AG - Defense World
A Piece Of The Puzzle Missing From Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) 26% Share Price Climb - simplywall.st
BNP Paribas Financial Markets Invests $2.03 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Price Target Raised to $48.00 - Defense World
The Manufacturers Life Insurance Company Acquires 2,144 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Increased by Northern Trust Corp - Defense World
Comerica Bank Acquires 2,919 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences (NASDAQ:HRMY) Upgraded at Cantor Fitzgerald - Defense World
Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | - GuruFocus
Harmony Biosciences (HRMY): Mizuho Raises Price Target to $48 | HRMY Stock News - GuruFocus
Mizuho raises Harmony Biosciences stock target to $48 - Investing.com
Harmony Biosciences (HRMY) Sees Price Target Increase Following Positive Q1 Results | HRMY Stock News - GuruFocus
Mizuho raises Harmony Biosciences stock target to $48 By Investing.com - Investing.com India
Mizuho Raises Price Target on Harmony Biosciences to $48 From $44, Keeps Outperform Rating - marketscreener.com
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $48 at Mizuho - StreetInsider
HARMONY BIOSCIENCES REITERATES CONFIDENCE IN WAKIX® (PITOLISANT) PATENTS FOLLOWING FAVORABLE DECISION BY U.S. PATENT AND TRADEMARK OFFICE (USPTO) TO DENY PETITION FOR REEXAMINATION - Seeking Alpha
Why Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings Are Better Than They Seem - simplywall.st
We Like Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings For More Than Just Statutory Profit - Yahoo Finance
Where are the Opportunities in (HRMY) - news.stocktradersdaily.com
Investors who lost money on Harmony Biosciences Holdings, Inc. should contact Levi & Korsinsky about an ongoing investigationHRMY - ACCESS Newswire
Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2025 Earnings Call Transcript - Insider Monkey
Harmony Biosciences Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Harmony Biosciences (HRMY) Maintains "Buy" Rating with $49 Price Target | HRMY Stock News - GuruFocus
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Call Hi - GuruFocus
Decoding Harmony Biosciences Holdings Inc (HRMY): A Strategic SW - GuruFocus
Harmony Biosciences Reports Strong Q1 2025 Results - TipRanks
Harmony Biosciences Reports Strong Earnings and Growth - TipRanks
Harmony Biosciences Holdings, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences reports Q1 EPS $1.03, consensus 91c - TipRanks
Harmony Biosciences Q1 2025 Earnings Call Transcript - MarketBeat
Harmony (HRMY) Reports Increase in Cash and Investments | HRMY S - GuruFocus
Harmony Biosciences (HRMY) Receives Buy Rating Reiteration by Ne - GuruFocus
Harmony Biosciences Q1 Adjusted Earnings, Revenue Increase; 2025 Sales Outlook Reiterated - marketscreener.com
Deep Dive Into Harmony Biosciences Hldgs Stock: Analyst Perspectives (13 Ratings) - Benzinga
Harmony Biosciences (HRMY) Receives Buy Rating Reiteration by Needham | HRMY Stock News - GuruFocus
Harmony Biosciences Holdings, Inc. (HRMY) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Harmony Biosciences Q1 2025 Earnings: EPS of $0.78 and Revenue o - GuruFocus
Harmony Biosciences Holdings, Inc. SEC 10-Q Report - TradingView
Harmony Biosciences (HRMY) Reports Q1 Revenue Surpassing Expecta - GuruFocus
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance ? | HRMY Stock News - GuruFocus
Harmony (HRMY) Reports Increase in Cash and Investments | HRMY Stock News - GuruFocus
Harmony Biosciences (HRMY) Reports Q1 Revenue Surpassing Expectations | HRMY Stock News - GuruFocus
Harmony Biosciences Holdings, Inc Q1 Profit Increases, Beats Estimates - Nasdaq
6.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):